158 related articles for article (PubMed ID: 24215194)
1. Patient selection for thromboprophylaxis in medical inpatients.
Bozzato S; Squizzato A; Donadini MP; Guasti L; Dentali F; Ageno W
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1639-47. PubMed ID: 24215194
[TBL] [Abstract][Full Text] [Related]
2. Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?
Greig MF; Rochow SB; Crilly MA; Mangoni AA
Age Ageing; 2013 Jul; 42(4):428-34. PubMed ID: 23557678
[TBL] [Abstract][Full Text] [Related]
3. Do medical patients need to receive pharmacologic prophylaxis for the prevention of venous thromboembolism?
Ageno W
Intern Emerg Med; 2012 Oct; 7 Suppl 3():S189-92. PubMed ID: 23073856
[TBL] [Abstract][Full Text] [Related]
4. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
Harrington DW
Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
[TBL] [Abstract][Full Text] [Related]
5. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
Ageno W; Spyropoulos AC; Turpie AG
Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we under-treating our patients?
Roth-Yelinek B
Eur J Intern Med; 2012 Apr; 23(3):236-9. PubMed ID: 22385880
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
8. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
9. Defining the population in need of thromboprophylaxis - making hospitals safer.
Baglin T
Br J Haematol; 2010 Jun; 149(6):805-12. PubMed ID: 20433681
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
Laporte S; Mismetti P
Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
[TBL] [Abstract][Full Text] [Related]
13. Relevance of immobility and importance of risk assessment management for medically ill patients.
Hull RD
Clin Appl Thromb Hemost; 2013 Jun; 19(3):268-76. PubMed ID: 22826444
[TBL] [Abstract][Full Text] [Related]
14. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
16. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency.
Cook DJ; Douketis J; Arnold D; Crowther MA
Curr Opin Pulm Med; 2009 Sep; 15(5):455-62. PubMed ID: 19617833
[TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis in ambulatory lung cancer treatment.
Cavaliere L
Clin J Oncol Nurs; 2013 Feb; 17(1):74-9. PubMed ID: 23372099
[TBL] [Abstract][Full Text] [Related]
18. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
[TBL] [Abstract][Full Text] [Related]
19. A review of venous thromboembolism prophylaxis for hospitalized medical patients.
Bozarth AL; Bajaj N; Abdeljalil A
Hosp Pract (1995); 2013 Aug; 41(3):60-9. PubMed ID: 23948622
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prevention in acutely ill nonsurgical patients.
Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
